According to Acasti Pharma latest financial reports the total liabilities of ACST is $11.17M, an decrease of -45.12% to 2022. At the end of 2022 company had $20.35M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Acasti Pharma is responsible for during its operational activities.
Year | Total liabilities | Change |
---|---|---|
2023 | $11.17M | -45.12% |
2022 | $20.35M | 199.35% |
2021 | $6.80M | -31.05% |
2020 | $9.86M | 204.74% |
2019 | $3.24M | - |